Swiss pharma firm Roche posts increased 2025 revenue

Swiss pharmaceutical firm Roche posted total sales of CHF61.5 billion last year, an increase of 2% from 2024. looks back on a successful financial year 2025. + Get the most important news from Switzerland in your inbox Roche has met its own targets and the outlook for the future also promises further growth, the group announced on Thursday. At constant exchange rates, this represents an increase of 7%, thus achieving its own target of growth in the mid-single-digit percentage range. While the Pharmaceuticals division increased its turnover by 3% to CHF47.7 billion, revenue in the Diagnostics business was 3% lower at CHF13.8 billion. Volume-orientated procurement in China slowed growth last year, the company said. Roche reported a net profit of CHF13.8 billion in 2025, compared to CHF9.2 billion in the previous year. According to Roche, this was due to the strong operating performance and base effects due to impairments in 2024. Core operating profit, which analysts use as a ...